By categorising obesity as a disease, public health systems and medical aid schemes around the world would be more likely to ...

In Part 1 of this Spotlight special briefing, we looked at some of the big picture dynamics of HIV in South Africa, and in ...

QIMR Berghofer-led research in collaboration with Australian oncology company Kazia Therapeutics has found that combining the drug candidate paxalisib with immunotherapy triggered a molecular ...

Analysts at Citi said that while the clinical hold impacts the targeted commercial launch of the GS-1720/GS-4182 regimen, previously expected around 2029/2030, they believe the setback is minor, as it ...

The U.S. Food and Drug Administration has paused Gilead Sciences' trials testing a combination of two of its experimental HIV ...

Gilead underscored its faith in the combo therapy and pledged to work with regulators to resolve the hold, which has paused ...

A new injection to prevent HIV is expected to be approved by the US Food and Drug Administration (FDA) later this month.